Visualizing Progress for TP53 Mutant AML: A Pathology-Guided Journey through Diagnostic Principles and Modern Treatment
0.50 hr(s) | ABIM , ABPath , CC , CME , MOC
Therapeutic Area(s): Oncology
Release Date: May 5, 2021
Expiration Date: May 4, 2022
Location: Internet Activity Enduring
In this activity, an expert pathologist discusses the prognostic relevance of TP53 mutations, current diagnostic tools and principles for capturing TP53-mutated acute myeloid leukemia (AML), and new developments with innovative therapy for TP53-mutated AML.